Freenome to Participate in the Piper Sandler 38th Annual Healthcare Conference
Freenome, Inc. announced that its management team will participate in a fireside chat at the Piper Sandler 38th Annual Healthcare Conference on December 1, 2026.
Stocks · News reference
Guggenheim analyst Subbu Nambi initiates coverage on Freenome (NASDAQ:FRNM) with a Buy rating and announces Price Target of $21.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Freenome, Inc. announced that its management team will participate in a fireside chat at the Piper Sandler 38th Annual Healthcare Conference on December 1, 2026.
Freenome, Inc. announced its financial results for the third quarter ended September 30, 2026, reporting $183.5 million in total revenue and providing updated guidance for the full year 2026.
Alphabet's Q3 13F filing reveals a new investment in Freenome, holding approximately 2.02 million shares.
Filed: 2026-10-20 AccNo: 0001140361-26-040186 Size: 205 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
– Personalized Cancer Detection provides flexible approach to cover multiple types of cancer screening in a single blood draw –– In an independent cohort, SimpleScreen Lung showed 85% sensitivity at 50% specificity and